Communiqués Beta Bionics, Inc. CBOE

Actions

BBNX

US08659B1026

Equipement et technologie médicale avancés

Temps réel CBOE 21:59:56 14/09/2026			Varia. 5j.	Varia. 1 janv.
16,72 ^USD	+0,78%		-14,70%	-45,52%

16:47	Beta Bionics, Inc. : Truist Securities toujours positif	ZM
15:05	Beta Bionics abaisse ses prévisions de chiffre d'affaires pour 2026 et reçoit l'homologation de la FDA pour sa pompe patch Mint	MT

Communiqués

13:30	Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm	GL
13:01	Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas	AQ
09/09	Berger Montague PC Investigating Claims on Behalf of Investors in Beta Bionics, Inc. (BBNX) After Class Action Filing	NE
08/09	Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	BU
29/07	Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance	GL
01/07	Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026	GL
09/06	Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth	NE
03/06	Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel	BU
02/06	Beta Bionics Investors Who Suffered Losses May Be Eligible for Recovery-Learn More Today, Contact Johnson Fistel	NE
02/06	Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website	GL
02/06	Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website	AQ
02/06	Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders	BU
21/05	Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development	GL
21/05	Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development	AQ
27/04	Beta Bionics to Present at the Bank of America Securities Health Care Conference	GL
21/04	Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance	GL
31/03	Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care	GL
30/03	Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026	GL
28/03	BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR
26/03	BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	NE
20/03	Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX)	NE
17/03	SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX)	PR
12/03	INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR
09/03	INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	NE
05/03	INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics	PR